ArborGen revenue up 78% but PBT barely moved, NPAT flattered by tax benefit

What changed

Revenue rose 78.4% to US$13.2m (HY23: US$7.4m), but the operating result improved only marginally: operating loss narrowed to US$0.8m from US$0.9m and PBT improved just 6.3% to a US$1.5m loss. NPAT, however, jumped to a US$0.1m loss from a US$1.6m loss — a 93.8% improvement driven by a US$1.4m tax credit rather than by operations. Operating cash flow swung to a US$2.1m inflow from a US$2.4m outflow. Gross borrowings fell to US$21.0m from US$25.9m and net debt edged down to US$16.7m from US$17.5m, but cash on hand roughly halved to US$4.3m from US$8.4m. Inventory climbed to US$46.7m from US$42.0m.

What matters

• PBT is the cleaner read. The 87.5pp gap between PBT growth (+6.3%) and NPAT growth (+93.8%) is driven entirely by a tax benefit; the effective tax rate swung to roughly -93% versus 0% prior. Strip that out and the underlying operating improvement is modest despite a 78% top-line lift.
• Cash conversion improved, but only in dollar terms. OCF of US$2.1m is a meaningful swing, yet capex rose to US$2.9m (from US$2.4m), leaving pre-lease free cash flow still negative at approximately -US$0.8m. The cash balance halving to US$4.3m tightens the liquidity runway.
• Leverage is directionally improving. Gross borrowings fell US$4.9m and equity is broadly stable at US$148.6m, consistent with a deleveraging posture — though net debt/EBITDA is not meaningful with EBITDA at -US$0.5m.

Expectations

No quantified target or formal guidance was disclosed. The seasonality context is informative: HY23 represented only 13.2% of FY23 revenue (US$7.4m of US$56.1m), confirming a heavily second-half weighted pattern. Annualised HY24 revenue of US$26.4m is still roughly 47% of the FY23 US$56.1m base, so the raw half-on-half growth needs to be read against a structurally back-loaded year. The release flags a lower-than-expected cone harvest following a late-2022 freeze, which is a supply-side headwind that the first-half numbers alone cannot resolve.

Quality of result

Moderate at best. The headline NPAT improvement is tax-driven, not operational. The operating cash flow swing is real but is partly explained by a US$3.2m reduction in trade receivables — a working-capital release rather than earnings quality. Inventory days improved to roughly 644 from 1,033, which is helpful, but inventory in absolute terms still rose US$4.7m and remains very high relative to half-year revenue. Adjusted US GAAP EBITDA of -US$0.5m is disclosed without a full reconciliation bridge to statutory earnings, limiting confidence in the non-GAAP measure. The durable components are the lower gross borrowings and the receivables release; the tax benefit and the seasonal revenue uplift are not.

Unresolved

• Current-period gross margin was not extracted, so whether the 78% revenue lift translated to margin expansion or dilution is unknown.
• No segment breakdown is available to identify where the revenue growth originated and whether Brazil (flagged in prior commentary) remains the dominant contributor.
• No detailed reconciliation of Adjusted US GAAP EBITDA to statutory results was provided.
• The cone-harvest shortfall is qualitatively flagged but not quantified in terms of FY24 revenue or margin impact.
• With cash at US$4.3m and pre-lease FCF still negative, the second-half funding picture and covenant headroom are not addressable from the extracted data.

This briefing cannot assess customer concentration, full-year guidance trajectory, or the magnitude of the freeze-related supply impact on FY24.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.